The #COVID19 outbreak has been hard for everyone, especially #RareDisease patients, who often struggle with weakened immune systems. With #CentoSwab™ physicians can quickly detect SARS-CoV-2 ─ accelerating treatments for high-risk populations. More: https://t.co/St2sFhbwit pic.twitter.com/iairenVAgg
— CENTOGENE (@Centogene) April 27, 2020
This week #CENTOGENE launched the COVID-19 Epidemic Response (COVER) Study ─ a new clinical trial aimed at characterizing factors predicting severity of symptoms in elderly SARS-CoV-2 positive individuals. Learn more: https://t.co/29LNnvbbDD#COVID19 #Research #Biomarkers pic.twitter.com/gJdd194El3
— CENTOGENE (@Centogene) April 28, 2020
https://t.co/oAKiTX5CbD Auf dem Weg zu Massentests mit Centogene
— Kiosque de Paris (@KiosqueDeParis) April 29, 2020
No comments:
Post a Comment